ProPhase Labs (NASDAQ: PRPH) reported Q3 EPS of ($0.16), $0.05 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $880 thousand versus the consensus estimate of $5.69 million.

For earnings history and earnings-related data on ProPhase Labs (PRPH) click here.